XOB: A novel phenylalkylamine antagonist of 5-HT2A receptors and voltage-gated sodium channels.
Denomme N, Hernandez CC, Bock HA, Ohana RF, Bakshi S, Sherwood AM, McCorvy JD, Daley PF, Callaway WB, Hull JM, Alt A, Isom LL, Cozzi NV.
Denomme N, et al. Among authors: bakshi s.
Mol Pharmacol. 2024 May 31:MOLPHARM-AR-2023-000837. doi: 10.1124/molpharm.123.000837. Online ahead of print.
Mol Pharmacol. 2024.
PMID: 38821630
Free article.